Drug companies defrauded Medicare of millionsBMJ 2001; 323 doi: http://dx.doi.org/10.1136/bmj.323.7317.828/a (Published 13 October 2001) Cite this as: BMJ 2001;323:828
- Fred Charatan
A joint venture of Takeda Chemical Industries and Abbott Laboratories—TAP Pharmaceutical Products—has agreed to pay $875m (£583) to settle criminal and civil charges that it had illegally manipulated the Medicare and Medicaid programmes.
The settlement tops the $840m paid by the healthcare company HCA for fraud (BMJ 2001;322:10). Federal prosecutors said that sales representatives from TAP gave doctors free samples of leuprorelin acetate (marketed as Lupron in the United States and Prostap in the United Kingdom), which is used to treat prostate cancer …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial